Changes in mortality rates and hospital mortality associated with bronchial asthma in the population of the Russian Federation (2014 – 2018)

Q4 Medicine

Pulmonologiya Pub Date : 2023-02-09 DOI:10.18093/0869-0189-2023-33-4-454-460

Е.В.Быстрицкая, Т.Н.Биличенко, E. Bystritskaya, T. Bilichenko

{"title":"Changes in mortality rates and hospital mortality associated with bronchial asthma in the population of the Russian Federation (2014 – 2018)","authors":"Е.В.Быстрицкая, Т.Н.Биличенко, E. Bystritskaya, T. Bilichenko","doi":"10.18093/0869-0189-2023-33-4-454-460","DOIUrl":null,"url":null,"abstract":"Bronchial asthma (BA) is one of the leading chronic non-communicable diseases in all age groups and has been noted by WHO and GINA due to the large socio-economic burden on society. Aim. The analysis of mortality rates (MR) and hospital mortality (HM) due to BA in the Russian population in 2014 and 2018. Methods. The statistical information of the Ministry of Healthcare of the Russian Federation and Federal State Statistics Service of the Ministry of Economic Development of the Russian Federation on the MR and HM associated with BA was used. Results. The mortality rate (MR) associated with BA in Russia was 1.2 per 100 thousand population in 2014 and 0.9 in 2018, which corresponded to 2% of mortality from all respiratory diseases. The maximum MR was registered in the Volga Federal District (in 2014 – 1.7, in 2018 – 1.1 per 100 thousand population). Among the working age population, the average MR due to BA was registered at the level of 0.4 per 100 thousand in 2014 and 0.3 in 2018. Among the population older than working age, MR was 4.2 in 2014. In 2018, MR due to BA decreased by 1.5 times to 2.7 per 100 thousand in the older age group (p = 0,026). MR due to BA in the urban population in 2018 was 2 times higher than in the rural population, and was 1.6 times higher in women than in men. Hospital mortality (HM) in the adult population in 2014 and 2018 stayed at the level of 0.3%. Conclusion. The early diagnosis and follow-up of patients with asthma and control of asthma among different age groups contribute to gradual decrease in MR.","PeriodicalId":37383,"journal":{"name":"Pulmonologiya","volume":"42 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pulmonologiya","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18093/0869-0189-2023-33-4-454-460","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Bronchial asthma (BA) is one of the leading chronic non-communicable diseases in all age groups and has been noted by WHO and GINA due to the large socio-economic burden on society. Aim. The analysis of mortality rates (MR) and hospital mortality (HM) due to BA in the Russian population in 2014 and 2018. Methods. The statistical information of the Ministry of Healthcare of the Russian Federation and Federal State Statistics Service of the Ministry of Economic Development of the Russian Federation on the MR and HM associated with BA was used. Results. The mortality rate (MR) associated with BA in Russia was 1.2 per 100 thousand population in 2014 and 0.9 in 2018, which corresponded to 2% of mortality from all respiratory diseases. The maximum MR was registered in the Volga Federal District (in 2014 – 1.7, in 2018 – 1.1 per 100 thousand population). Among the working age population, the average MR due to BA was registered at the level of 0.4 per 100 thousand in 2014 and 0.3 in 2018. Among the population older than working age, MR was 4.2 in 2014. In 2018, MR due to BA decreased by 1.5 times to 2.7 per 100 thousand in the older age group (p = 0,026). MR due to BA in the urban population in 2018 was 2 times higher than in the rural population, and was 1.6 times higher in women than in men. Hospital mortality (HM) in the adult population in 2014 and 2018 stayed at the level of 0.3%. Conclusion. The early diagnosis and follow-up of patients with asthma and control of asthma among different age groups contribute to gradual decrease in MR.

查看原文本刊更多论文

俄罗斯联邦人口中支气管哮喘相关死亡率和住院死亡率的变化(2014 - 2018年)

支气管哮喘(BA)是所有年龄组中主要的慢性非传染性疾病之一，由于给社会造成巨大的社会经济负担，已被世卫组织和GINA注意到。的目标。2014年和2018年俄罗斯人口BA死亡率(MR)和住院死亡率(HM)分析方法。使用俄罗斯联邦卫生部和俄罗斯联邦经济发展部联邦国家统计局关于与BA相关的MR和HM的统计信息。结果。俄罗斯与BA相关的死亡率(MR)在2014年为每10万人1.2人，在2018年为每10万人0.9人，相当于所有呼吸道疾病死亡率的2%。伏尔加联邦区登记的最高MR(2014年为1.7,2018年为每10万人1.1)。在劳动年龄人口中，2014年因BA导致的平均MR为每10万人0.4,2018年为0.3。在超过工作年龄的人口中，2014年的MR为4.2。2018年，老年人群因BA引起的MR下降了1.5倍，为每10万人2.7例(p = 0.026)。2018年，城市人口中因BA引起的MR比农村人口高2倍，女性比男性高1.6倍。2014年和2018年，成人住院死亡率(HM)保持在0.3%的水平。结论。不同年龄组哮喘患者的早期诊断和随访以及哮喘的控制有助于MR的逐渐降低。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pulmonologiya Medicine-Pulmonary and Respiratory Medicine

CiteScore

1.40

自引率

0.00%

发文量

期刊介绍： The aim of this journal is to state a scientific position of the Russian Respiratory Society (RRS) on diagnosis and treatment of respiratory diseases based on recent evidence-based clinical trial publications and international consensuses. The most important tasks of the journal are: -improvement proficiency qualifications of respiratory specialists; -education in pulmonology; -prompt publication of original studies on diagnosis and treatment of respiratory diseases; -sharing clinical experience and information about pulmonology service organization in different regions of Russia; -information on current protocols, standards and recommendations of international respiratory societies; -discussion and consequent publication Russian consensus documents and announcement of RRS activities; -publication and comments of regulatory documents of Russian Ministry of Health; -historical review of Russian pulmonology development. The scientific concept of the journal includes publication of current evidence-based studies on respiratory medicine and their discussion with the participation of Russian and foreign experts and development of national consensus documents on respiratory medicine. Russian and foreign respiratory specialists including pneumologists, TB specialists, thoracic surgeons, allergists, clinical immunologists, pediatricians, oncologists, physiologists, and therapeutists are invited to publish article in the journal.